跳到正文
原文
FDA Guidance Documents·· 原文未提供具体时分

Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals, De Novo Classifications, and Humanitarian Device Exemptions: Guidance for Industry and Food and Drug Administration Staff

Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals, De Novo Classifications, and Humanitarian Device Exemptions: Guidance for Industry and Food and Drug Administration Staff

AI 导读

FDA 官方历史目录记录;Final guidance;发布日期:2019-08-30。官方主题:Postmarket, Premarket Approval (PMA), HUD/HDE。请通过官方原文与附件查阅文件。

来源:FDA Guidance Documents · fda.gov